Browse the evidence

The metabolically healthy obese (MHO) phenotype is characterized by preserved insulin sensitivity and favorable metabolic markers despite high body fat, primarily driven by reduced visceral and ectopic (liver) fat accumulation and healthy adipose tissue expansion.

If you are obese but metabolically healthy (normal blood pressure, lipids, and insulin sensitivity), your risk profile is significantly better than that of an obese person with metabolic abnormalities. Focus on maintaining this metabolic health through healthy lifestyle habits, as MHO is not a permanent state and conversion to unhealthy status occurs in ~30% of cases over 5-10 years, often due to aging or weight gain.

Preserved mitochondrial function and healthy adipose tissue expansion (via angiogenesis and adiponectin secretion) are key mechanisms that prevent ectopic fat storage and insulin resistance in metabolically healthy obese individuals.

Maintaining healthy adipose tissue function through regular physical activity and avoiding excessive weight gain may help preserve mitochondrial health and prevent the shift from metabolically healthy to unhealthy obesity.

Acute damaging muscle-lengthening contractions trigger a temporal sequence of IGF-1 splice variant expression in human skeletal muscle, where Mechano Growth Factor (MGF) peaks early (24h) correlating with satellite cell proliferation markers (Myf5/MyoD), while IGF-1Ea and IGF-1Eb peak later (72h) correlating with differentiation markers (MRF4/myogenin).

This research highlights that muscle repair after intense exercise (like heavy eccentric training) relies on local molecular signals rather than blood hormone levels. Specifically, the body produces a variant called MGF early on (around 24 hours) to kickstart satellite cell proliferation, followed by other IGF variants (Ea/Eb) later (around 72 hours) to help cells differentiate and repair. For training, this implies that sufficient mechanical damage is required to trigger this specific local molecular cascade, and that recovery time allows these distinct phases to occur.

In healthy humans, disuse-induced muscle atrophy is primarily driven by a significant reduction in muscle protein synthesis (MPS), while muscle protein breakdown (MPB) remains largely unchanged.

If you are immobilized or inactive but healthy, your muscle loss is not because your body is actively destroying muscle tissue, but because it has stopped building it. The primary lever to prevent loss is to restore the stimulus for muscle protein synthesis (e.g., through resistance exercise or adequate protein intake) rather than focusing solely on preventing breakdown.

In disease states (e.g., sepsis, cancer, critical illness), muscle atrophy is driven by both elevated muscle protein breakdown (MPB) and reduced muscle protein synthesis (MPS), mediated by inflammatory cytokines.

If you have a disease involving inflammation (like cancer or sepsis), your muscle loss is driven by both increased breakdown and decreased synthesis due to inflammatory signals. Preventing loss requires addressing the underlying disease and inflammation, not just rest or exercise.

Intense cycling exercise activates MAPK (ERK1/2, p38) and AMPK signaling pathways in skeletal muscle, leading to downstream phosphorylation of MSK1 and histone H3, with untrained individuals exhibiting a greater signaling response than highly trained athletes at the same relative intensity.

If you are a trained athlete, standard moderate-intensity exercise may not trigger the same level of cellular signaling (MAPK/AMPK) as it does for beginners. To maintain these specific adaptive signals, you likely need to increase the intensity or volume of your training, as your muscles have adapted to be more resistant to these stimuli.

In overweight or obese individuals with type 2 diabetes, metabolic dyslipidemia (defined as high triglycerides and low HDL-C) is associated with a significantly higher risk of coronary artery disease and composite cardiovascular events, independent of LDL-C levels.

If you have Type 2 Diabetes and are overweight, your risk of heart disease is significantly higher if you have both high triglycerides and low HDL cholesterol, even if your LDL is normal. This risk exists independently of your LDL levels. You should discuss your triglyceride and HDL levels with your doctor as part of your cardiovascular risk assessment, not just your LDL.

Endurance exercise, but not resistance exercise, significantly enhances the phosphorylation of proteins responsible for glucose transport (AS160) and glycogen synthesis (Glycogen Synthase) during the early recovery period.

If you are trying to improve how your muscles handle glucose or replenish glycogen stores after a workout, endurance exercise is the more effective stimulus in the immediate recovery period. Resistance training, while great for muscle structure, does not trigger these specific glucose-handling signals as strongly in the first hour.

In young healthy men, larger baseline subcutaneous adipocyte size protects against overfeeding-induced insulin resistance and ectopic lipid accumulation, whereas smaller adipocytes are associated with worsened metabolic outcomes despite similar weight gain.

If you have larger subcutaneous fat cells, you may be metabolically protected against the negative effects of occasional overeating compared to someone with smaller cells. However, this does not mean overeating is safe; it still causes weight gain and some metabolic stress. Focus on long-term health rather than trying to 'shrink' fat cells, as smaller cells may actually predispose you to insulin resistance during periods of excess energy intake.

In Pima Indians, increased adiposity and hyperinsulinemia do not trigger the sympathetic nervous system (SNS) activation typically seen in whites, which contributes to a lower prevalence of hypertension despite high obesity rates.

This research suggests that the link between obesity and high blood pressure is not universal. For some populations (like Pima Indians), high body fat and insulin levels do not trigger the stress response (SNS) that usually raises blood pressure. This highlights that genetic background plays a critical role in how the body handles weight and stress.

In White males, increased body fat and hyperinsulinemia are positively associated with increased muscle sympathetic nerve activity (MSNA), which in turn is associated with higher blood pressure.

For White males, losing weight and managing insulin levels may help lower blood pressure by reducing sympathetic nervous system activity. This study confirms that in this group, higher body fat and insulin lead to higher stress signals (MSNA) and higher BP.

Non-optimal systolic blood pressure (SBP) is the leading metabolic risk factor for cardiometabolic mortality in the MENA region, causing 48% of deaths.

Monitor and manage blood pressure aggressively, as it is the number one metabolic driver of heart disease and diabetes deaths in the MENA region. Target levels below 115 mm Hg for optimal protection.

Bariatric surgery significantly reduces the overall incidence of cancer, obesity-related cancers, and cancer-associated mortality in patients with morbid obesity compared to conventional treatment.

For individuals with morbid obesity, bariatric surgery is a highly effective intervention for reducing the risk of developing various cancers, particularly obesity-related types like breast, colorectal, and endometrial cancer, as well as reducing cancer mortality. This benefit is attributed to sustained weight loss and metabolic improvements that are difficult to achieve through lifestyle changes alone.

Bariatric surgery significantly reduces the incidence of specific obesity-related cancers, including hepatocellular, colorectal, pancreatic, gallbladder, breast, endometrial, and ovarian cancers.

Bariatric surgery offers significant protection against several specific types of cancer, particularly those linked to obesity and hormones (breast, endometrial, ovarian) and metabolic factors (liver, colorectal, pancreatic, gallbladder).

Performing endurance exercise before resistance exercise attenuates the mRNA response of IGF-IEa (a growth factor) compared to performing resistance exercise before endurance exercise.

If you do cardio before weights, your body's expression of IGF-IEa (a growth factor) is reduced by 42% compared to doing weights first. If your goal is maximizing muscle growth signaling, prioritize resistance training before cardio in the same session.

Lifestyle interventions alone are often insufficient for long-term weight maintenance due to hormonal and metabolic adaptations that drive weight regain, necessitating adjunctive therapies for many patients.

If you regain weight after lifestyle changes, do not blame yourself. Your body's hormones and metabolism are adapting to store energy. This is a common biological response, and it is why medical guidelines recommend considering additional therapies (like medication) if lifestyle changes alone do not sustain your results.

Sulfonylureas are associated with weight gain, hypoglycemia, and declining long-term efficacy, making them unsuitable as first- or second-line treatments.

Avoid sulfonylureas if possible. They cause weight gain and low blood sugar, and their effectiveness fades over time. Use them only if other, safer options are not available or affordable.

Circulating very-long-chain saturated fatty acids (VLCSFAs) in erythrocytes are NOT significantly associated with a reduced risk of incident coronary heart disease (CHD) after multivariate adjustment.

Unlike plasma levels, erythrocyte levels of these specific fatty acids do not show a clear protective effect against heart disease in this study. This highlights that the location of the fatty acid (plasma vs. cell membrane) matters for its health impact.

Adipose tissue (AT) dysfunction, rather than fat mass alone, is the primary mechanistic link between obesity and adverse health outcomes, explaining why some individuals with obesity remain metabolically healthy while others with normal weight develop obesity-related diseases.

Your health risk from obesity is not just about how much you weigh, but how your fat tissue is functioning. Factors like visceral fat, inflammation, and insulin sensitivity matter more than BMI alone. Focus on metabolic health markers rather than just the scale.

Roux-en-Y gastric bypass (RYGB) induces weight loss and metabolic improvements through complex neurohormonal mechanisms (incretins, vagal signaling, microbiome shifts) rather than solely through mechanical restriction or malabsorption.

Surgery works by changing your gut hormones and brain signals, not just by making your stomach smaller. This hormonal shift helps control hunger and blood sugar. Post-surgery, you must follow dietary guidelines to support these new hormonal balances.

Silencing or deficiency of the mitochondrial Complex IV subunit COX5B in white adipose tissue drives intracellular lipid accumulation and adipocyte enlargement, whereas restoring COX5B expression counteracts age-dependent obesity.

This research suggests that age-related weight gain is driven by a specific decline in mitochondrial efficiency (Complex IV) in fat cells, regulated by the HIF1A protein. While you cannot directly 'dose' COX5B, the findings imply that strategies supporting mitochondrial health and reducing chronic hypoxic stress in adipose tissue may help prevent age-related fat accumulation. For humans, higher COX5B levels are associated with better weight loss outcomes after bariatric surgery, suggesting this biomarker has prognostic value.

Long-acting GLP-1 receptor agonists (liraglutide and semaglutide) activate POMC neurons and inhibit NPY/AgRP neurons in vivo, with effects occurring 12-24 hours post-injection and dependent on the TRPC5 channel and metabolic state.

Long-acting GLP-1 drugs like liraglutide and semaglutide change brain activity related to hunger and energy use, but this happens slowly, peaking 12-24 hours after injection. This effect is stronger when you are fasting. The drug works by activating specific brain cells (POMC) that reduce hunger and inhibiting others (NPY/AgRP) that increase it, using a channel called TRPC5.

Bariatric surgery does not provide superior long-term cardiovascular benefits (specifically blood pressure and cholesterol) compared to non-surgical treatments.

While surgery is excellent for weight and diabetes, do not assume it automatically fixes heart health long-term. Monitor blood pressure and cholesterol closely, as non-surgical management may sometimes match or exceed surgical benefits in these specific areas over many years.

Older adults (64-78 years) exhibit an impaired ability to regulate food intake after weight loss, resulting in sustained lower body weight and significantly reduced hunger perception compared to young normal-weight adults.

For older adults, the biological drive to eat (hunger) may naturally decrease after weight loss, which can help maintain a lower weight without conscious effort. This is a biological shift, not a failure of willpower. If you are older and find you don't feel as hungry after losing weight, this is a normal physiological response that may help you maintain your new weight.